Concerted Activation of ETS Protein ER81 by p160 Coactivators, the Acetyltransferase p300 and the Receptor Tyrosine Kinase HER2/Neu
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Activator of thyroid and retinoic acid receptor (ACTR) is overexpressed in approximately 60% of primary human breast tumors and belongs to the p160 steroid receptor coactivator family. In this study, we identified a novel interaction partner of ACTR, the ETS transcription factor ER81 that is also heavily implicated in mammary tumor formation. ACTR and related p160 family members (steroid receptor coactivator-1 and glucocorticoid receptor-interacting protein-1 (GRIP-1)) augment ER81-mediated transcription. Although ACTR and GRIP-1 can acetylate ER81, this posttranslational modification of ER81 is not required for its stimulation by ACTR or GRIP-1. In addition, ACTR collaborates with the p300 coactivator, a joint interaction partner of ACTR and ER81, to stimulate ER81 function and the ability of p300 to acetylate ER81 is indispensable for this collaboration. Furthermore, the receptor tyrosine kinase HER2/Neu, an oncoprotein particularly found overexpressed in breast tumors, cooperates with both ACTR and p300 to stimulate ER81-mediated transcription. Thus, oncogenic HER2/Neu and ACTR may synergize to orchestrate mammary tumorigenesis through the dysregulation of the transcription factor ER81 and its target genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, direct interactions between CBP and p300 have been reported for SPI1 (117–118) and ETV1 (119, 120).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
Anzick, S. L., Kononen, J., Walker, R. L., Azorsa, D. O., Tanner, M. M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J. M., & Meltzer, P. S. (1997) · Science · doi:10.1126/science.277.5328.965 · Cited by 1,639
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,465
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
Torchia, J., Rose, D. W., Inostroza, J., Kamei, Y., Westin, S., Glass, C. K., & Rosenfeld, M. G. (1997) · Nature · doi:10.1038/42652 · Cited by 1,283
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M.-J., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,243
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S.-M., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,211
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Research works printed but not linked: 7
- Bautista, S., Valles, H., Walker, R. L., Anzick, S., Zeillinger, R., Meltzer, P., and Theillet, C. (1998) Clin. Cancer Res. 4, 2925-2929
- Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Kimura, A., Nakamura, Y., Inazawa, J., Abe, T., and Yamagishi, H. (2000) Int. J. Cancer 89, 217-223 · doi:10.1002/1097-0215(20000520)89:3<217::aid-ijc2>3.0.co;2-6
- Trimble, M. S., Xin, J. H., Guy, C. T., Muller, W. J., and Hassell, J. A. (1993) Oncogene 8, 3037-3042
- Janknecht, R., and Nordheim, A. (1993) Biochim. Biophys. Acta 1155, 346 -356
- Janknecht, R., Ernst, W. H., and Nordheim, A. (1995) Oncogene 10, 1209 -1216
- Janknecht, R. (2002) Histol. Histopathol. 17, 657-668
- Bouras, T., Southey, M. C., and Venter, D. J. (2001) Cancer Res. 61, 903-907
Cited by
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Xu, J., Wu, R.-C., & O'Malley, B. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2695 · Cited by 488
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
Self-citationSteroid Receptor Coactivator (SRC) Family: Masters of Systems Biology
York, B., & O'Malley, B. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.193367 · Cited by 230
Qin, L., Liao, L., Redmond, A., Young, L., Yuan, Y., Chen, H., O'Malley, B. W., & Xu, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00579-08 · Cited by 186
EWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
Self-citationTootle, T. L., & Rebay, I. (2005) · BioEssays · doi:10.1002/bies.20198 · Cited by 175
Li, C., Ao, J., Fu, J., Lee, D.-F., Xu, J., Lonard, D., & O'Malley, B. W. (2011) · Oncogene · doi:10.1038/onc.2011.151 · Cited by 173
The Steroid Receptor Coactivator-1 Regulates Twist Expression and Promotes Breast Cancer Metastasis
Qin, L., Liu, Z., Chen, H., & Xu, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4389 · Cited by 163
Fleming, F. J., Myers, E. A., Kelly, G., Crotty, T. B., McDermott, E. W. M., O’Higgins, N. J., Hill, A. D. K., & Young, L. S. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.016733 · Cited by 129
Hamada, S., Kim, T., Suzuki, T., Itoh, Y., Tsumoto, H., Nakagawa, H., Janknecht, R., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.098 · Cited by 128
Self-citationMyers, E., Hill, A. D. K., Kelly, G., McDermott, E. W. M., O’Higgins, N. J., Buggy, Y., & Young, L. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1192 · Cited by 123
Wang, S., Yuan, Y., Liao, L., Kuang, S.-Q., Tien, J. C.-Y., O'Malley, B. W., & Xu, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808703105 · Cited by 122
Yan, J., Erdem, H., Li, R., Cai, Y., Ayala, G., Ittmann, M., Yu‐Lee, L., Tsai, S. Y., & Tsai, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0955 · Cited by 117
Sumoylation of p68 and p72 RNA Helicases Affects Protein Stability and Transactivation Potential
Mooney, S. M., Grande, J. P., Salisbury, J. L., & Janknecht, R. (2009) · Biochemistry · doi:10.1021/bi901263m · Cited by 127
Self-citationThe JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
Kim, T., Shin, S., Berry, W. L., Oh, S., & Janknecht, R. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24009 · Cited by 107
Self-citationHistone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1
Kim, T., Jin, F., Shin, S., Oh, S., Lightfoot, S. A., Grande, J. P., Johnson, A. J., van Deursen, J. M., Wren, J. D., & Janknecht, R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci78132 · Cited by 110
Self-citationSRC-3/AIB1: transcriptional coactivator in oncogenesis1
Yan, J., Tsai, S. Y., & Tsai, M. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00315.x · Cited by 103
Shin, S., Kim, T.-D., Jin, F., van Deursen, J. M., Dehm, S. M., Tindall, D. J., Grande, J. P., Munz, J.-M., Vasmatzis, G., & Janknecht, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0941 · Cited by 85
Self-citationLiu, C., Sarkaria, J. N., Petell, C. A., Paraskevakou, G., Zollman, P. J., Schroeder, M. A., Carlson, B. L., Decker, P. A., Wu, W., James, C. D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1306 · Cited by 91
Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D
Kim, T., Oh, S., Shin, S., & Janknecht, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034618 · Cited by 84
Self-citationMcIlroy, M., McCartan, D. P., Early, S. A., Gaora, P. Ó., Pennington, S. R., Hill, A. D. K., & Young, L. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3713 · Cited by 73
Regulation of SRC-3 Intercompartmental Dynamics by Estrogen Receptor and Phosphorylation
Amazit, L., Pasini, L., Szafran, A. T., Berno, V., Wu, R., Mielke, M., Jones, E. D., Mancini, M. G., Hinojos, C. A., O’Malley, B. W., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01695-06 · Cited by 79
Pleiotropic Effects of p300-mediated Acetylation on p68 and p72 RNA Helicase
Mooney, S. M., Goel, A., D’Assoro, A. B., Salisbury, J. L., & Janknecht, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143792 · Cited by 72
Self-citationA Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein
Pop, M. S., Stransky, N., Garvie, C. W., Theurillat, J.-P., Hartman, E. C., Lewis, T. A., Zhong, C., Culyba, E. K., Lin, F., Daniels, D. S., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0689 · Cited by 65
Chung, A. C., Zhou, S., Liao, L., Tien, J. C.-Y., Greenberg, N. M., & Xu, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3168 · Cited by 67
Keld, R. R., Guo, B., Downey, P., Cummins, R., Gulmann, C., Ang, Y. S., & Sharrocks, A. D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.187 · Cited by 65
Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer
Alazawi, D. K., McIlroy, M., Kelly, G., Redmond, A. M., Bane, F., Cocchiglia, S., Hill, A. D. K., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210964 · Cited by 68
Kim, T., Fuchs, J. R., Schwartz, E. B., Abdelhamid, D. S., Etter, J. P., Berry, W. L., Li, C., Ihnat, M. A., Li, P., & Janknecht, R. (2014) · Europe PMC (PubMed Central) · Cited by 75
Self-citationRcl is a novel ETV1/ER81 target gene upregulated in breast tumors
Shin, S., Bosc, D. G., Ingle, J. N., Spelsberg, T. C., & Janknecht, R. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21884 · Cited by 63
Self-citationHistone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10
Kim, J., Shin, S., Subramaniam, M., Bruinsma, E. S., Kim, T., Hawse, J. R., Spelsberg, T. C., & Janknecht, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.068 · Cited by 58
Self-citationHsia, E. Y. C., Kalashnikova, E. V., Revenko, A. S., Zou, J. X., Borowsky, A. D., & Chen, H.-W. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0095 · Cited by 62
McCartan, D. P., Bolger, J. C., Fagan, A., Byrne, C., Yuan, H., Qin, L., McIlroy, M., Xu, J., Hill, A. D. K., Gaora, P. Ó., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1976 · Cited by 62
Association of NCOA3 Polymorphisms with Breast Cancer Risk
Burwinkel, B., Wirtenberger, M., Klaes, R., Schmutzler, R. K., Grzybowska, E. A., Försti, A., Frank, B., Bermejo, J. L., Bugert, P., Wappenschmidt, B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1621 · Cited by 54
Stimulation of β-catenin and colon cancer cell growth by the KDM4B histone demethylase
Berry, W. L., Kim, T., & Janknecht, R. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2279 · Cited by 55
Self-citationSoria, J. M., Taglialatela, P., Gil-Perotin, S., Galli, R., Gritti, A., Verdugo, J. M. G., & Bertuzzi, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3248-04.2004 · Cited by 51
Nikolai, B. C., Lanz, R. B., York, B., Dasgupta, S., Mitsiades, N., Creighton, C. J., Tsimelzon, A. I., Hilsenbeck, S. G., Lonard, D. M., Smith, C. S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2383 · Cited by 49
ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells
Shin, S., Oh, S., AN, S., & Janknecht, R. (2012) · Oncology Reports · doi:10.3892/or.2012.2079 · Cited by 52
Self-citation14-3-3 Proteins Modulate the ETS Transcription Factor ETV1 in Prostate Cancer
Oh, S., Shin, S., Lightfoot, S. A., & Janknecht, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0578 · Cited by 43
Self-citationOhguri, T., Hisaoka, M., Kawauchi, S., Sasaki, K., Aoki, T., Kanemitsu, S., Matsuyama, A., Korogi, Y., & Hashimoto, H. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.034942 · Cited by 42
DiTacchio, L., Bowles, J., Shin, S., Lim, D., Koopman, P. A., & Janknecht, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.320101 · Cited by 43
Self-citationLi, L. B., Louie, M. C., Chen, H.-W., & Zou, J. X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.013 · Cited by 46
ETS transcription factor ERG cooperates with histone demethylase KDM4A
Kim, T., Shin, S., & Janknecht, R. (2016) · Oncology Reports · doi:10.3892/or.2016.4747 · Cited by 40
Self-citationKavanagh, D. O., McIlroy, M., Myers, E., Bane, F. T., Crotty, T. B., McDermott, E. W. M., Hill, A. D. K., & Young, L. S. (2010) · Endocrine Related Cancer · doi:10.1677/erc-09-0216 · Cited by 42
Sui, Y., Jiang, H., Kellogg, C. M., Oh, S., & Janknecht, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122238 · Cited by 32
Self-citationHER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer
Chandran, V. I., Eppenberger‐Castori, S., Venkatesh, T., Vine, K. L., & Ranson, M. (2015) · Oncoscience · doi:10.18632/oncoscience.146 · Cited by 31
Fabris, S., Mosca, L., Cutrona, G., Lionetti, M., Agnelli, L., Ciceri, G., Barbieri, M., Maura, F., Matis, S., Colombo, M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23340 · Cited by 34
Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice
Chen (1992) · International Journal of Oncology · doi:10.3892/ijo_00000177 · Cited by 28
Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer
Sui, Y., Li, X., Oh, S., Zhang, B., Freeman, W. M., Shin, S., & Janknecht, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65536-6 · Cited by 29
Self-citationOh, S., Shin, S., Song, H., Grande, J. P., & Janknecht, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-44685-3 · Cited by 26
Self-citationModerate overexpression of AIB1 triggers pre‐neoplastic changes in mammary epithelium
Avivar, Á., García-Macías, M. C., Ascaso, E., Herrera, G., O’Connor, J., & de Mora, J. F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.057 · Cited by 25
Kalet, B. T., Anglin, S. R., Handschy, A. V., O’Donoghue, L. E., Halsey, C., Chubb, L. S., Korch, C. T., & Duval, D. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068815 · Cited by 30
Role of the Nuclear Receptor Coactivator AIB1-Δ4 Splice Variant in the Control of Gene Transcription
Chien, C. D., Kirilyuk, A., Li, J. V., Zhang, W., Lahusen, T. J., Schmidt, M. O., Oh, A. S., Wellstein, A., & Riegel, A. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216200 · Cited by 25
Li, X., Oh, S., Song, H., Shin, S., Zhang, B., Freeman, W. M., & Janknecht, R. (2018) · Oncology Letters · doi:10.3892/ol.2018.9487 · Cited by 24
Self-citationOh, S., Song, H., Freeman, W. M., Shin, S., & Janknecht, R. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5133 · Cited by 25
Self-citationEndocrine resistance in breast cancer
Zheng, L.-L., Zhao, Y., Feng, H., & Liu, Y. J. (2013) · Climacteric · doi:10.3109/13697137.2013.864268 · Cited by 21
Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases
Li, X., Moon, G., Shin, S., Zhang, B., & Janknecht, R. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8507 · Cited by 21
Self-citationTranscriptional repression of the tumor suppressor DRO1 by AIB1
Ferragud, J., Avivar‐Valderas, A., Pla, A., Rivas, J. D. L., & de Mora, J. F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.025 · Cited by 20
NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease
Sandford, A. J., Malhotra, D., Boezen, H. M., Siedliński, M., Postma, D. S., Wong, V., Akhabir, L., He, J., Connett, J. E., Anthonisen, N. R., et al. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00027.2012 · Cited by 20
Androgen up-regulation of Twist1 gene expression is mediated by ETV1
Khatiwada, P., Kannan, A., Malla, M., Dreier, M. R., & Shemshedini, L. (2020) · PeerJ · doi:10.7717/peerj.8921 · Cited by 20
Jean, A., Gutierrez‐Hartmann, A., & Duval, D. L. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0279 · Cited by 21
Ranzani, M., Annunziato, S., Calabria, A., Brasca, S., Benedicenti, F., Gallina, P., Naldini, L., & Montini, E. (2014) · Molecular Therapy · doi:10.1038/mt.2014.174 · Cited by 17
Upregulation of PSMD10 caused by the JMJD2A histone demethylase.
Kim, T., Oh, S., Lightfoot, S. A., Shin, S., Wren, J. D., & Janknecht, R. (2016) · PubMed · Cited by 18
Self-citationVarışlı, L., Dancik, G. M., Tolan, V., & Vlahopoulos, S. (2023) · Cancers · doi:10.3390/cancers15215242 · Cited by 15
Generation and Validation of a Mouse Line with a Floxed SRC-3/AIB1 Allele for Conditional Knockout
Liu, Z., Liao, L., Zhou, S., & Xu, J. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.202 · Cited by 16
Hsia, E. Y. C., Zou, J. X., & Chen, H. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87008-7 · Cited by 16
Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer.
Oh, S., Shin, S., & Janknecht, R. (2021) · International Journal of Clinical and Experimental Pathology · Cited by 19
Self-citationDuval, D. L., Jonsen, M. D., Diamond, S. E., Murapa, P., Jean, A., & Gutierrez‐Hartmann, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0245 · Cited by 13
Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks
Qu, K., Abi-Haidar, A., Fan, J., Ensman, L. M., Tuncay, K., Jolly, M. S., & Ortoleva, P. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.12.002 · Cited by 11
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A
Gu, R., Kim, T.-D., Song, H., Sui, Y., Shin, S., Oh, S., & Janknecht, R. (2023) · JCI Insight · doi:10.1172/jci.insight.164990 · Cited by 13
Self-citationPetit, F. G., Salas, R., Tsai, M., & Tsai, S. Y. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.03.009 · Cited by 14
Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis
Gu, R., Kim, T., Jiang, H., Shin, S., Oh, S., & Janknecht, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1295613 · Cited by 9
Self-citationThe role of p300 in the tumor progression of oral squamous cell carcinoma
Cho, Y., Hong, J., Choe, E., Yoon, H., Hong, S., Lee, J., & Hong, S. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12227 · Cited by 8
Co-activator SRC-1 is dispensable for transcriptional control by STAT3
Cvijic, H., Bauer, K., Löffler, D., Pfeifer, G., Blumert, C., Kretzschmar, A. K., Henze, C., Brocke-Heidrich, K., & Horn, F. (2009) · Biochemical Journal · doi:10.1042/bj20081989 · Cited by 10
Edgerton, M. E., Fisher, D., Tang, L., Frey, L. J., & Chen, Z. (2007) · PubMed Central · Cited by 8
Edgerton, M. E., Fisher, D., Tang, L., Frey, L. J., & Chen, Z. (2007) · Cancer Informatics · doi:10.1177/117693510700300016 · Cited by 9
Anti-tumor activity of CDYL2b in prostate cancer
Gu, R., Janknecht, J., Oh, S., Jiang, H., & Janknecht, R. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217987 · Cited by 3
Self-citationKim, T., Gu, R., & Janknecht, R. (2023) · PubMed Central · Cited by 3
Self-citationPromotion of breast cancer by the DNPH1 enzyme
Oh, S., Sui, Y., Shin, S., & Janknecht, R. (2026) · iScience · doi:10.1016/j.isci.2026.115227 · Cited by 2
Self-citationThree reactive compartments in venous malformations
Bartnick, K., Dörge, H., Becker, J., Schweigerer, L., Ebenebe, C. U., Diehl, S., & Wilting, J. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0021 · Cited by 1
Wehmeyer, L. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
Hadley, K. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 2
AIB1: A Transcriptional Coactivator Which Integrates Signaling Cross Talk in Cancer Cells
Ferrero, M., & de Mora, J. F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0730-0_7
NCOA3 (nuclear receptor coactivator 3)
Anzick, S. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38207
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Chung, A. C.-K., Zhou, S., Liao, L., Tien, J. C.-Y., Greenberg, N. M., & Xu, J. (2023) · doi:10.1158/0008-5472.c.6495207.v1
Chung, A. C.-K., Zhou, S., Liao, L., Tien, J. C.-Y., Greenberg, N. M., & Xu, J. (2023) · doi:10.1158/0008-5472.c.6495207
McCartan, D. P., Bolger, J. C., Fagan, A., Byrne, C., Hao, Y., Li, Q., McIlroy, M., Xu, J., Hill, A. D. K., Gaora, P. Ó., et al. (2023) · doi:10.1158/0008-5472.c.6503220.v1
Shin, S., Kim, T., Jin, F., van Deursen, J. M., Dehm, S. M., Tindall, D. J., Grande, J. P., Munz, J.-M., Vasmatzis, G., & Janknecht, R. (2023) · doi:10.1158/0008-5472.c.6499190.v1
Self-citationIdentification et caractérisation de nouveaux partenaires du facteur de transcription ERM
Verreman, K. (2009) · theses.fr (ABES) · doi:10.70675/bf47548ezef04z448az86a3zbfc948ca93fe
Ladam, F. (2010) · theses.fr (ABES) · doi:10.70675/e175f6dbz92dez451cza5a0z5ba11dc8c915
DNPH1 exerts context-dependent tumor-promoting and -repressing functions during melanoma development
Sui, Y., Oh, S., & Janknecht, R. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.09.843
Self-citationJacquemart, I. (2006) · TigerPrints (Clemson University)
Metadata
- Authors
- Goel, A., & Janknecht, R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Janknecht, Ralf
- ORCID
- Janknecht, Ralf
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 279
- Issue
- 15
- Pages
- 14909-14916
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2029169609
- Cited by
- 95
- References
- 65
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 9 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2016: 5 · 2015: 2 · 2014: 6 · 2013: 3 · 2012: 6
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6042 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fraternal Order of Eagles
- Mayo Foundation for Medical Education and Research
- National Cancer Institute (R01CA085257, CA085257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- ER81, ETS transcription factors, ACT-R, p160 coactivators, P300, HER2/neu, protein acetylation, transcriptional activation, breast cancer, mammary carcinogenesis, SRC-1, protein-protein interaction
- MeSH terms
- p300-CBP-Associated Factor, Acetyltransferases, Animals, Breast Neoplasms, Carrier Proteins, Cell Line, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Glutathione Transferase, HeLa Cells, Humans, Luciferases, Models, Biological, Nuclear Proteins, Plasmids, Precipitin Tests, Protein Binding, Protein Processing, Post-Translational, Recombinant Fusion Proteins, RNA, Transcription Factors, Transcription, Genetic, RNA-Binding Proteins, Protein Structure, Tertiary, Receptors, Retinoic Acid, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Cell Cycle Proteins, Reverse Transcriptase Polymerase Chain Reaction, Nucleocytoplasmic Transport Proteins, p300-CBP Transcription Factors, Histone Acetyltransferases, Nuclear Receptor Coactivator 2, Nuclear Receptor Coactivator 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.